Adverse remodeling of the right ventricle (RV) that affects RV systolic or diastolic function directly or indirectly by modulating changes to cavitary geometry is a principal determinant of poor outcome across the global spectrum of cardiopulmonary diseases 1, 2 . Indeed, even subclinical increases in RV mass are associated with substantially elevated risk for future heart failure and decreased lifespan 3 . Unique embryological and anatomic features of the RV provide a pathophysiological basis by which to account for this observation. For example, precursor cells of the RV and left ventricle (LV) derive from the primary and anterior heart fields 4 , respectively, indicating a different cellular lineage for each ventricle despite their close proximity and placement in series. In contrast to the LV, the RV is a triangular-shaped structure that is thinwalled and non-compacted, and, thus, tolerates pressure-loading conditions poorly 5 . Moreover, poor coronary blood flow reserve with increased RV strain due to elevations in wall tension is associated with decreased RV microvascular perfusion 6 .
Although these properties establish the RV-specific pressure-volume relationship profile, factors that precipitate impaired RV performance are less well characterized. Take for example the wide swath of classical reports that describe LV hemodynamic (patho)physiological responses to acute and chronic myocardial ischemia, systemic hypertension, valvular dysfunction, and pericardial disease 7 . By contrast, a paucity of data exist to characterize the mechanistic and clinical contribution of similar processes (including LV dysfunction) to the natural history of adverse RV remodeling in non-congenital heart disease patients, despite the attendant clinical relevance of RV failure. Furthermore, the basic mechanism(s) that underpin RV dysfunction when contemporaneous with pulmonary hypertension, the most common endpathophenotype associated with changes to RV loading 8 , are largely unknown. In fact, only recently has consideration been given to RV function within the context of the larger lungwalled and non-compacted, and, thus, tolerates pressure-loading conditions poor rl ly ly 5 5 5 . Mo Mo More re reov ov over er, ,
poor coronary blood flow reserve with increased RV strain due to elevations in wall tension is as sso so oci ci ciat at ated ed ed w w wi it ith de de dec cr creased RV microvascular per r rfu fu f s s sion 6 .
Althou ugh gh gh t the hese se p p pro ro ope pe pert rt tie ies s es es esta tab bl bli ish t t the e e RV V V--spe ec eci if ific ic c p pre res ss su ur re-e vo vo olu u ume me e r r rel elat at tio io ions ns n h hi h p p p pr prof of ofi ile, fa act ct ctor or rs s s th that at t pr pr p ec eci ip ipi it itat ate e e i imp mp m ai ai ire r r d d d RV RV RV p per er e fo fo form rm rman an ance ce e a ar re l les s ss s s we we well ll ll c cha ha ara ra ract ct ter eriz iz i ed ed d. . Ta Ta T k ke ke f for r r ex xa xam m mpl le le he wide swa ath th th o o of f f cl cl clas as ssi si ica cal l l re re repo po port rt rts s s th th that t t de de desc sc scri ri ribe be be L L LV V V he h h mo mo mody dy dyna na nami mi m c (p (p (pat at atho ho ho)p )p )phy hy ysi si siol ol olog og ogic ic i al pulmonary circulatory-RV apparatus 5, 9 . This is a critical distinction, however, because defining the right heart axis in this way reidentifies the RV as a specific participant in the pathobiology of pulmonary hypertension and potential therapeutic target per se, thereby parting from traditional dogma in which RV dysfunction is a consequence of pulmonary vascular disease, an indicator of irreversible cardiac injury, and a dismal prognostic marker.
Current work in the field has advanced our understanding of RV myocyte pathobiology significantly in the context of pulmonary vascular disease, particularly with respect to maladaptive molecular mechanisms that modulate RV failure through changes in cellular metabolism 10 , nitric oxide bioavailability 11, 12 , and ion channel dysfunction 13 . These basic and translational scientific models, which emphasize novel RV-specific targets to improve RV performance, have illuminated a number of cell signaling pathways with future therapeutic promise for patients afflicted with PH-induced RV dysfunction.
Notwithstanding these cutting edge discoveries, however, a substantial knowledge gap persists with respect to the fundamental mechanism by which classical cardiovascular effectors associated with low cardiac output states may promote circulatory failure vis-à-vis RV dysfunction, such as upregulation of neurohumoral signaling that is linked to unfavorable clinical outcome in patients with congestive heart failure due to LV dysfunction 14 . For example, only recently has overactivation of the renin-angiotensin axis been described systematically in patients with pulmonary arterial hypertension (PAH) and RV remodeling 15 .
Hyperalodsteronism, long recognized as a mediator of poor outcome in congestive heart failure due to LV dysfunction, now appears to be present in the pulmonary arterial circulation of PAH patients in the absence of abnormal LV remodeling or impaired function, and correlates positively with adverse pulmonary vascular remodeling 16 . Others have reported recently on ranslational scientific models, which emphasize novel RV-specific targets to im mp p prov o o e e RV RV RV performance, have illuminated a number of cell signaling pathways with future therapeutic pr rom om mis is ise e e fo fo for r r p pati ien en ent ts ts afflicted with PH-induced R R RV V V d dysfunction.
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Second, little mechanistic (or clinical) data are available to inform clinicians on the consequences of repurposing pharmacotherapies commonly used to manage LV heart failure, such as -or -adrenergic receptor (ant)agonists, to patients with pulmonary hypertension and RV dysfunction, despite the frequency with which this occurs in clinical practice 18 . Thus, investigating the functional consequences of neurohumoral hormones on RV and/or LV performance in the context of RV failure is a timely and attractive avenue of investigation.
In the current edition of Circulation, Piao and colleagues 13 Collectively, these observations provide a comprehensive evaluation of catecholaminedependent changes to RV function in pulmonary hypertension, and identify provocative differences in the molecular profile of RV myocytes based on acute vs. chronic temporal patterns of RV injury. Although the mechanism(s) by which to account for these differences were not addressed fully in this work, obvious future endeavors are likely to include characterizing these differences further, as well as accounting for the observation that inhibition of GRK2 improved RV contractile reserve without attendant changes to 1 -receptor expression levels. This finding functional capacity in RV failure. Thirdly, the investigators demonstrate superior r orit i i y y y of of f dobutamine over dopamine for enhancing RV systolic function in the tested models, an ob bse se serv rv rva atio ion n n th th hat t i i is s in internally consistent with thei ei ir r r f fi indings of dysf sf fun u ct ctio io i n nal D t 1 receptors in RV m myo oc ocytes, wh hic ich h h i in nte ter rac ct ct w wit it th h h do dopa pa pami mine ne e and d d n n not d do o obut ut utam am amin in ine e e. T To o m make ke e t thi his s s d de dete term rm min in inat at tio o on n, a a a t cl clev ev ver er er e e exp xp xper er eri im imen en enta ta al l l de d desi si ign gn g w w was as a use se sed d in in n w w whi hi hic ch h h th th the e e ef ef ffe fe fect ct c s s s of of of i ion on onot ot otro ro ope pe pes s s wa wa was s as as asse se sess ss sse ed ed i i in n n se se sepa pa para ra ate te t RV and LV V La La Lang ng ngen en endo do dorf rf ff f mo mo mode d d ls ls ls, , th th he er e eb eb eby y y al al llo lo lowi wi wing ng ng f f for or o t t the he he a a ass ss s es es essm sm s en en ent t t of of of c c con on o tr tr rac ac acti ti ile le le r r re eserve in raises the possibility that inhibition of GRK2 may modulate beneficial effects on RV performance, at least in part, indirectly via off-target suppression of GRK2-dependent catecholamine hyperactivity in adrenal tissue 20 . Moreover, the observation that in one model of chronic (but not acute) RV heart failure, downregulation of 1 -adrenergic signaling was noted in both RV and LV myocardium is intriguing, and may ultimately prove to be an important clue in identifying (mal)adaptive cross-talk between RV and LV cardiomyocyte cell signaling pathways involved in regulating ionotropic reserve. ignaling pa ath th thwa wa ways ys ys i i in n n pa pa p ti tien en ents ts t w wit it th h he he h ar ar art t fa fa fail il i ur ur ure e e fr fr f om om om R R RV V V an an nd/ d/ d/or o or L LV V V dy dy dysf sf sfun un u ct ct tio io ion. n. I I In n n th t t is way,
